NCT01828931 Lifestyle Intervention for Diabetes and Weight Management in Psychosis Status COMPLETED Phase NA
NCT01818453 Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression? Status COMPLETED Phase NA
NCT01814085 A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression Status COMPLETED Phase PHASE4
NCT01812291 Evaluation of a Stepped Care Approach to Manage Depression in Diabetes Status COMPLETED Phase NA
NCT01808651 A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing Status COMPLETED Phase PHASE3
NCT01808612 A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing Status COMPLETED Phase PHASE3
NCT01795326 Physician Survey on Monitoring of Patients Treated With Quetiapine Status COMPLETED Phase N/A
NCT01793324 EMR Data to Assess Monitoring of Patients Treated With Quetiapine Status COMPLETED Phase N/A
NCT01787240 Neurobiological Bases of Placebo Response in Major Depressive Disorder Status TERMINATED Phase PHASE4
NCT01774045 A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression Status COMPLETED Phase PHASE1
NCT01769859 Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders Status TERMINATED Phase N/A
NCT01764867 Algorithm Guided Treatment Strategies for Major Depressive Disorder Status UNKNOWN Phase PHASE4
NCT01752608 Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder Status WITHDRAWN Phase NA
NCT01742832 Double-Blind Treatment of Major Depressive Disorder With Vilazodone Status COMPLETED Phase PHASE2
NCT01741142 Efficacy and Safety Study of ABT-436 in Major Depressive Disorder Status TERMINATED Phase PHASE2